Pharmafile Logo

Peter Impey

- PMLiVE

The new EU clinical trial lay summaries

New regulations will require both a trial summary and a lay person’s summary

- PMLiVE

Genital herpes vaccine candidate promising in phase II

Genocea Biosciences’ GEN-003 found to reduce recurrence and transmission of the virus

- PMLiVE

European sites

What makes a country in Europe attractive to life science companies?

- PMLiVE

LEO Pharma appoints J&J’s Michael Hinchy

He takes up the role of dermatology director for the UK and Ireland

EU flag

EMA initiative aims to fast-track important new drugs

Hopes PRIME programme will foster greater cooperation with industry 

- PMLiVE

Rare disease therapies head the ‘class of 2015’

Last year’s approvals included a number of first-in-class compounds

- PMLiVE

Changing behaviour by design

Are we underestimating the power of design in encouraging behaviours for the good of our health?

- PMLiVE

Measurement: It’s time to get with the real world

We’ve known for years how important it is to exercise, to manage the amount of calories we eat and to sleep well. Over the last five years, we have been...

- PMLiVE

The Italian Job

Therapy efficacy and value-based reimbursement models

Why does content need a strategy?

Not all organisations are in a position to look at maturity – for some, there’s still a pressing question that needs answering: Why does content need a strategy? Content Marketing...

Blue Latitude Health

- PMLiVE

Astellas’ EMEA president Ken Jones resigns

He will be succeeded by the firm's marketing head Yukio Matsui

- PMLiVE

FDA approves wireless contact lens sensor

Triggerfish allows monitoring of eye pressure for 24 hours

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links